FNY Investment Advisers »

Phoenix Biotech Acquisition Class A shares owned by FNY Investment Advisers

Quarter-by-quarter ownership of Phoenix Biotech Acquisition Class A (CERO) shares owned by FNY Investment Advisers from 13F filings

Historical chart of FNY Investment Advisers investment in Phoenix Biotech Acquisition Class A

Tip: Access up to 7 years of quarterly data

All positions including Phoenix Biotech Acquisition Class A held by FNY Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phoenix Biotech Acquisition Class A by FNY Investment Advisers

Quarter filed Position value Share count Share price at filing
2024-03-31 $32k 11k 3.05
2023-06-30 $22k 2.1k 10.56

More positions owned by FNY Investment Advisers

Tritium Dcfc (DCFC)
Byrna Technologies (BYRN)
Proshares Tr Bitcoin Strate (BITO)
General Electric (GE)
Pepsi (PEP)
Advisorshares Tr (MSOS)
Broadcom (AVGO)
Michael Kors Holdings Ord (CPRI)
NVIDIA Corporation (NVDA)
3M Company (MMM)
Solventum Corp
Amazon (AMZN)
Bank of America Corporation (BAC)
Hess (HES)
Pioneer Natural Resources (PXD)

View all positions for FNY Investment Advisers

Top funds holding Phoenix Biotech Acquisition Class A

Arch Venture Corp
Sc China Holding
Jane Street
Geode Capital Management
FNY Investment Advisers
Kestra Private Wealth Services
Pineridge Advisors
Jpmorgan Chase & Co

View all funds holding Phoenix Biotech Acquisition Class A